Oncology · Phase III

Top sponsors

• AstraZeneca 75 programs
• Chinese Academy of 70 programs
• HOFFMANN-LA ROCHE 68 programs
• MSD Merck Sharp 56 programs
• First People's Hospital 53 programs
• Ningbo Cancer Hospital 44 programs
• United Therapeutics Europe 43 programs
• Anaxis Pharma 37 programs
• AstraZeneca 37 programs
• Novartis India 32 programs
• George Institute for 29 programs
• Takeda 28 programs

1. ZD6474 (vandetanib)

   Sanofi Pasteur

   Non-Small-Cell Lung Carcinoma

   phase 3 · small molecule · completed

   1 trial →

2. ZWI-ZW25-301

   Jazz Pharmaceuticals Ireland Limited

   Gastroesophageal Adenocarcinoma (GEA)

   phase 3 · small molecule · active

   1 trial →

3. Zanidatamab

   BEONE MEDICINES AUS PTY LTD

   Gastric Neoplasms

   phase 3 · small molecule · active

   1 trial →

4. Zanidatamab

   Jazz Pharmaceuticals Ireland Limited

   Biliary Tract Cancer

   phase 3 · small molecule · active

   1 trial →

5. Zanidatamab

   Jazz Pharmaceuticals Ireland Limited

   Metastatic HER2-positive Breast Cancer

   phase 3 · small molecule · active

   1 trial →

6. Zanubrutinib

   BEONE MEDICINES AUS PTY LTD

   Relapsed/Refractory Follicular Lymphoma

   phase 3 · small molecule · active

   1 trial →

7. Zanubrutinib

   BEONE MEDICINES AUS PTY LTD

   Chronic Lymphocytic Leukemia

   phase 3 · small molecule · active

   2 trials →

8. Zanubrutinib

   BeiGene

   Chronic Lymphocytic Leukemia

   phase 3 · small molecule · completed

   1 trial →

9. Ziftomenib

   Kura Oncology

   Acute Myeloid Leukemia (AML)

   phase 3 · small molecule · active

   1 trial →

10. Zilovertamab vedotin

    Merck KGaA, Darmstadt, Germany

    Diffuse Large B-Cell Lymphoma

    phase 3 · mab · active

    1 trial →

11. Zimberelimab

    Arcus Biosciences

    Non-small Cell Lung Cancer

    phase 3 · small molecule · active

    2 trials →

12. Zoledronic acid

    Novartis Pharmaceuticals

    Breast Cancer

    phase 3 · small molecule · completed

    1 trial →

13. Zometa 4 mg/100 ml solution for infusion

    Ningbo Cancer Hospital

    High grade osteosarcoma

    phase 3 · small molecule · active

    1 trial →

14. [18F]-AlF-FAPI-74

    Disc Medicine

    Carcinoma of Unknown Primary

    phase 3 · small molecule · active

    1 trial →

15. [18F]-AlF-FAPI-74

    Disc Medicine

    Advanced gastric cancer

    phase 3 · small molecule · active

    1 trial →

16. [18F]-AlF-FAPI-74 for Cholangiocarcinoma

    Disc Medicine

    Cholangiocarcinoma

    phase 3 · small molecule · active

    1 trial →

17. [68Ga]Ga-PentixaFor, FLUDEOXYGLUCOSE (18F)

    Alphapharm Pty Ltd

    Marginal Zone Lymphoma

    phase 3 · small molecule · active

    1 trial →

18. a patient self-reporting applet

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cancer Pain

    phase 3 · other · active

    1 trial →

19. adoptive immunotherapy

    Chinese PLA General Hospital

    Hepatocellular Carcinoma

    phase 3 · mab · completed

    1 trial →

20. asparaginase

    United Therapeutics Europe Ltd

    Lymphoma

    phase 3 · small molecule · active

    1 trial →

21. asparaginase

    Children's Hospital of Fudan University

    Leukemia

    phase 3 · small molecule · completed

    2 trials →

22. bempegaldesleukin

    Nektar Therapeutics UK Limited

    Renal Cell Carcinoma

    phase 3 · mab · terminated

    1 trial →

23. bendamustine

    Teva Pharma GmbH

    Non-Hodgkin's Lymphoma

    phase 3 · small molecule · completed

    2 trials →

24. bexarotene

    Eisai Co.,

    Non-small Cell Lung Cancer

    phase 3 · small molecule · completed

    1 trial →

25. brentuximab vedotin

    Takeda

    Hodgkin Lymphoma

    phase 3 · small molecule · completed

    3 trials →

26. brigatinib

    Takeda

    Non-Small Cell Lung Cancer

    phase 3 · small molecule · terminated

    2 trials →

27. canakinumab

    Novartis Pharmaceuticals

    Non-small Cell Lung Cancer

    phase 3 · small molecule · terminated

    2 trials →

28. cemiplimab

    Regeneron UK Limited

    Non-small Cell Lung Cancer

    phase 3 · small molecule · active

    3 trials →

29. cetuximab + cisplatin + vinorelbine

    Merck KGaA, Darmstadt, Germany

    Non Small Cell Lung Cancer (NSCLC)

    phase 3 · small molecule · completed

    1 trial →

30. chemotherapy and SHR-1316(Adebrelimab) comnined with surgery or radiotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Limited Stage Small Cell Lung Cancer

    phase 3 · other · active

    1 trial →

31. cisplatin

    United Therapeutics Europe Ltd

    Bladder Cancer

    phase 3 · small molecule · completed

    1 trial →

32. cisplatin

    Pari Pharma GmbH

    Lung Cancer

    phase 3 · small molecule · completed

    1 trial →

33. cisplatin i.p.

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Epithelial Carcinoma, Ovarian

    phase 3 · small molecule · active

    1 trial →

34. custirsen sodium

    Teva Pharma GmbH

    Castrate-Resistant Prostate Cancer

    phase 3 · small molecule · terminated

    1 trial →

35. cyclophosphamide

    Partner Therapeutics Limited

    Breast Cancer

    phase 3 · small molecule · completed

    1 trial →

36. cyclosporine

    Takeda

    Leukemia

    phase 3 · small molecule · terminated

    1 trial →

37. dactinomycin

    Children's Hospital of Fudan University

    Kidney Cancer

    phase 3 · mab · completed

    1 trial →

38. dactinomycin

    Solid Biosciences

    Sarcoma

    phase 3 · mab · active

    1 trial →

39. daraxonrasib

    Revolution Medicines

    NSCLC (Non-small Cell Lung Cancer)

    phase 3 · small molecule · active

    1 trial →

40. daraxonrasib

    Revolution Medicines

    Pancreatic Cancer

    phase 3 · small molecule · active

    2 trials →

41. decitabine

    The First People's Hospital of Lianyungang

    Acute Myelocytic Leukemia

    phase 3 · small molecule · active

    1 trial →

42. desiccated thyroid extract (DTE)+levothyroxine (L-T4)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Intermediate-to-High Risk Differentiated Thyroid Cancer

    phase 3 · small molecule · active

    1 trial →

43. doxorubicin hydrochloride

    United Therapeutics Europe Ltd

    Stage III Bladder Cancer

    phase 3 · small molecule · completed

    1 trial →

44. doxorubicin hydrochloride

    Children's Hospital of Fudan University

    Adult Alveolar Soft-part Sarcoma

    phase 3 · small molecule · completed

    1 trial →

45. doxorubicin in combination with palifosfamide-tris

    Alaunos Therapeutics

    Soft Tissue Sarcoma

    phase 3 · small molecule · completed

    1 trial →

46. educational internet site on prostate cancer screening

    United Therapeutics Europe Ltd

    Prostate Cancer

    phase 3 · other · completed

    1 trial →

47. erlotinib

    Hoffmann-La Roche

    Non-Squamous Non-Small Cell Lung Cancer

    phase 3 · small molecule · completed

    1 trial →

48. esophagectomy

    The First People's Hospital of Lianyungang

    Esophageal Cancer

    phase 3 · other · active

    1 trial →

Frequently asked questions